PM8002 Clinical Trials
5 recruitingDrug
Phase 23Phase 32Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 3
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
Triple Negative Breast Cancer(TNBC)
Biotheus Inc.360 enrolled70 locationsNCT06419621
Recruiting
Phase 3
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
SCLC
Biotheus Inc.404 enrolled45 locationsNCT06616532
Recruiting
Phase 2
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
Neuroendocrine Neoplasm
Biotheus Inc.60 enrolled13 locationsNCT05879055
Recruiting
Phase 1Phase 2
PM8002 in the Treatment of Patients With Advanced Solid Tumors
Malignant Neoplasm
Biotheus Inc.380 enrolled48 locationsNCT05918445
Recruiting
Phase 2
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
MPM
Biotheus Inc.55 enrolled1 locationNCT05918107